No attachments available.
Erlotinib Tablets
Contact and place of performance
Adam Hernandez
USA
No narrative description provided for this notice.
The National Institutes of Health, National Cancer Institute, issued an award notice for Erlotinib Tablets under solicitation number 75N91020Q00004. This procurement is classified under NAICS code 325412, Pharmaceutical Preparation Manufacturing, and PSC code 6505, Drugs and Biologicals. The award was processed as a Small Business Administration (SBA) set-aside.
The place of performance is located within the United States, and the primary point of contact for this action is Adam Hernandez. Published on January 27, 2020, the notice confirms the fulfillment of requirements for these pharmaceutical supplies without accompanying attachments or a narrative scope of work. All information regarding this procurement is sourced from the award details published on SAM.gov.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.